Global Metagenomics Market to Reach $3.2 Billion by 2028 at a CAGR of 13.6%

News provided by

Dec 23, 2022, 06:15 ET

DUBLIN, Dec. 23, 2022 /PRNewswire/ -- The "Global Metagenomics Market Size, Share & Industry Trends Analysis Report by Workflow, Product (Kits & Reagents, Sequencing & Data Analytics Services and Software), Technology, Application, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

The Global Metagenomics Market size is expected to reach $3.2 billion by 2028, rising at a market growth of 13.6% CAGR during the forecast period.

It demonstrated that cultivation-based approaches have missed the large bulk of microbial biodiversity. Metagenomics has the potential to transform knowledge of the whole living universe as a result of its ability to uncover the hitherto hidden diversity of microorganisms. As the cost of DNA sequencing continues to decline, metagenomics now enables the investigation of microbial ecology on a much larger scale and in greater depth than ever before.

Recent studies use "shotgun" or PCR-directed sequencing to obtain largely unbiased samples of all genes from all sampled community members. The term metagenome referred to the concept that a collection of sequenced environmental genes might be studied similarly to a single genome. As a source of DNA, conventional sequencing begins with a culture of identical cells. However, early metagenomic investigations indicated that broad groups of microbes in several habitats could not be cultivated and hence cannot be sequenced.

Multiple 16S rRNA sequences that do not correspond to any known cultured species have been discovered, indicating the existence of numerous non-isolated organisms. These surveys of ribosomal RNA genes extracted directly from the environment demonstrated that cultivation-based approaches detect less than one percent of the bacterial and archaeal organisms in a sample. The discovery that the great majority of microorganisms were previously unrecognized is largely responsible for the growing popularity of metagenomics.

Market Growth Factors

Constant Technological Advancements In NGS Platforms

Continuous technological advancements in sequencing techniques have enabled the development of efficient, portable, and user-friendly NGS platforms that are capable of delivering speedy and accurate results and have a reduced turnaround time. The introduction of such products and technology offers players an immediate competitive advantage; hence, leading companies are investing more in R&D to increase their market positions and shares. Many new bioinformatics tools have been added to the metagenomics market as a result of technical improvements, which have increased the market's revenue.

NGS Data Analysis With Big Data

The amount of data generated during whole-genome sequencing is often at the terabyte level. For end-users of NGS-based metagenomic sequencing, data management is a significant challenge. Due to differences in data formats and the lack of an industry-wide standard for data output from different NGS platforms, data storage requirements can be rather complex. The application of big data technologies and AI for NGS analysis and workflow management has considerably boosted the yield of NGS runs. With developments in sequencing technology, the quantity of data collected during a sequencing run likewise grows.

Market Restraining Factors

Constrained End-User Budgets In Developing Nations

Academic research and development are almost entirely reliant on financial support from other sources in nations that are still considered to be developing. NGS sequencers continue to be prohibitively costly even though the cost of NGS sequencing has come down. The NovaSeq 5000 and 6000 are Illumina's two most sophisticated sequencing systems, and their prices range from hundreds to tens of thousands of US dollars.

COVID-19 Impact Analysis

Since the emergence of COVID-19, important players in the life sciences and biotechnology industries have sought solutions for COVID-19 tracking, diagnosis, and treatment. The analysis of metagenomics is vital for the discovery and tracking of the virus. Diverse sequencing monitoring solutions and platforms are being implemented for efficient infection diagnosis. In May 2021, for instance, Oxford University and Oracle established strategic cooperation to develop a robust cloud-based genomic sequencing and analysis platform to reduce the risk of coronavirus infection. Due to the exceptional demand for COVID-19medication and vaccine discovery, economic activity in the metagenomics market is accelerating.

Scope of the Study
By Workflow

Sequencing
Pre-sequencing
Data Analysis

By Product

Kits & Reagents
Sequencing & Data Analytics Services
Software

By Technology

Shotgun Sequencing
16S Sequencing
Whole Genome Sequencing
Others

By Application

Environmental
Clinical Diagnostics
Drug Discovery
Biotechnology
Food & Nutrition
Others

By Geography

North America

US
Canada
Mexico
Rest of North America

Europe

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Asia Pacific

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

LAMEA

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Key Market Players
List of Companies Profiled in the Report:

Bio-Rad Laboratories, Inc.
Illumina, Inc.
PerkinElmer, Inc.
Thermo Fisher Scientific, Inc.
Novogene Co., Ltd.
Promega Corporation
Qiagen N.V.
Takara Bio, Inc. (Takara Holdings Inc.)
Oxford Expression Technologies Ltd.
F. Hoffmann-La Roche Ltd.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Strategies deployed in Metagenomics Market

Chapter 4. Global Metagenomics Market by Workflow

Chapter 5. Global Metagenomics Market by Product

Chapter 6. Global Metagenomics Market by Technology

Chapter 7. Global Metagenomics Market by Application

Chapter 8. Global Metagenomics Market by Region

Chapter 9. Company Profiles